Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Arpad Szallasi

Department Of Pathology, Monmouth Medical Center, Long Branch, NJ 07740 United States

Biography

Arpad Szallasi is a leading expert on the roles of TRP channels in health and disease. He was the first to provide a biochemical proof for the existence of the vanilloid (capsaicin) receptor, now known as TRPV1. Currently, he holds an Associate Professor position at the 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Publications

Prognostic Significance of Preoperative Thrombocytosis in Patients withEndometrial Carcinoma: Our Experience and Review of the Literature

Objective: In this study, we aimed to determine the prevalence and prognostic significance of preoperative thrombocytosis (defined as platelet count ≥ 400 × 103/μl) in patients with endometrial carcinoma. Methods: This was a retrospective analysis of 389 consecutive patients diagnosed and treated at our Institution with endometrial ca... Read More»

Dongmin Gu, Tianhua Guo and Arpad Szallasi*

Review Article: Trends Gynecol Oncol 2016,1:101

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top